Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines

Journal of Pharmacology and Experimental Therapeutics

Volumn 299, Issue 2, 2001, Pages 645-651

  Kishimoto, Chiharu ^c   Takada, Hitoshi ^a   Kawamata, Hiroshi ^a   Umatake, Miho ^b   Ochiai, Hiroshi ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; SULFONATED IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG EFFECT; ENCEPHALOMYOCARDITIS VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE NECROSIS; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; CARDIOVIRUS INFECTIONS; CELL LINE; CYTOKINES; ENCEPHALOMYOCARDITIS VIRUS; HEART FAILURE, CONGESTIVE; IMMUNIZATION, PASSIVE; MICE; MYOCARDIUM; ORGAN SIZE;

EID: 0034757014     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin
2. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages
3. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity
4. Immunomodulation of encephalomyocarditis virus-induced disease in A/J mice
5. Mechanisms of therapeutic effect of high-dose intravenous immunoglobulin: Attenuation of acute complement-dependent immune damage in a guinea pig model
6. Intravenous immune globulin in the therapy of perium cardiomyopathy
7. Treatment of refractory immune thombocytopenic purpura with an anti-Fc-receptor antibody
8. Macrophage inflammatory proteins: Biology and role in pulmonary inflammation
9. Gammaglobulin treatment of acute myocarditis in the pediatric population
10. Hemodynamic effects of immuno-adsorption and subsequent immunoglobulin substitution in dilated cardiomypathy
11. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
12. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
13. Coxsackievirus B3-induced production of tumor necrosis factor-α II-1β and IL-6 in human monocytes
14. Treatment of systemic vasculitis with pooled intravenous immunoglobulin
15. Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes
16. Immunological behavior of lymphocytes in experimental viral myocarditis: Significance of T-lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice
17. Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood
18. Intravenous IgG: Supertherapy for myocarditis and acute dilated cardiomyopathy
19. Effect of high-dose intravenous immunoglobulin on serum chemistry hematology and lymphocyte subpopulations: Assessments based on controlled treatment trials in patients with neurological diseases
20. A clinical trial of immunosuppressive therapy for myocarditis
21. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy
22. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy
23. Posttranscriptional regulation of T-cell IL-2 production by human pooled immunoglobulin
24. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
25. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
26. Increased in vivo antibody activity against interferon γ, interleukin-1α, and interleukin-6 after high-dose Ig therapy
27. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
28. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis
29. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin
30. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects
31. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens
32. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillan-Barré syndrome
33. Polyclonal immunoglobulin therapy protects against cardiac damage in experimental coxsackievirus-induced myocarditis
34. Immunomodulatory effect of immunoglobulins
35. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases